MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a new generic version of the kidney stone medication, THIOLA EC®. The new drug, tiopronin delayed-release tablets, aims to provide a more affordable option for patients.
Scott Sims, Senior Vice President and General Manager of Endo, emphasized the company’s mission. “We’re proud to provide high-quality, affordable choices to healthcare providers and their appropriate patients,” Sims said. This launch enhances Endo’s generic product lineup and solidifies its reputation as a dependable supplier.
The medication is designed to work with other measures, such as high fluid intake, low-acid diets, and alkali usage, to prevent cystine kidney stones. It is suitable for both adults and children who are prone to this type of kidney stone.
Endo is also offering copay assistance for eligible patients. Those interested in the Patient Assistance Program can call (833) 727-4357 for more information.
THIOLA EC® is a registered trademark of Mission Pharmacal Company.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.